GlassScriptPhysician profile
Husam Alkhersam
NPI 1336124429
$12,626.48
in general payments reported to CMS, 2019-2025
58 companies · $1,756 in 2025
The $1,756 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,191 · 2020: $5,042 · 2021: $72.96 · 2022: $1,318 · 2023: $1,799 · 2024: $1,448 · 2025: $1,756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,923 · Education: $79.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,923.26 |
| Education | $79.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $4,867.54 | 2019-2020 | |
| Abbvie INC. | $1,921.86 | 2021-2025 | Botox, Qulipta, Ubrelvy |
| Teva Pharmaceuticals USA, INC. | $550.14 | 2019-2025 | Ajovy, Austedo, Austedo Xr |
| Pfizer INC. | $437.75 | 2022-2025 | |
| Tg Therapeutics, INC. | $316.99 | 2024-2025 | |
| Biogen, INC. | $312.97 | 2019-2025 | Vumerity, Tysabri, Leqembi |
| Ucb, INC. | $310.93 | 2019-2024 | Briviact, Fintepla |
| Genentech USA, INC. | $261.62 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Biohaven Pharmaceutical Holding Company LTD. | $248.35 | 2022 | |
| Mallinckrodt Hospital Products INC. | $217.95 | 2024-2025 | Acthar |
| Amgen INC. | $212.14 | 2021-2025 | Uplizna |
| Emd Serono, INC. | $211.36 | 2019-2024 | |
| Harmony Biosciences LLC | $204.97 | 2023-2025 | Wakix |
| Novartis Pharmaceuticals Corporation | $173.11 | 2019-2025 | |
| Genzyme Corporation | $151.96 | 2019-2022 |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $140.94 | 2019-2025 | Nuplazid |
| Sk Life Science, INC. | $131.80 | 2023-2024 | |
| Philips North America LLC | $120.53 | 2019 | |
| Octapharma USA, INC. | $111.40 | 2022-2023 | Panzyga, Octagam Immune Globulin (Human) |
| Sunovion Pharmaceuticals INC. | $109.43 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $102.07 | 2022-2025 | Rytary, Ongentys 50mg Capsules 30, Crexont |
| Lilly USA, LLC | $101.64 | 2019-2023 | Amyvid |
| Akcea Therapeutics, INC. | $95.93 | 2019 | |
| Csl Behring | $92.07 | 2019 | |
| Neurocrine Biosciences, INC. | $84.29 | 2019-2023 | Ongentys, Ingrezza |
| Sumitomo Pharma America, INC. | $80.93 | 2023 | Aptiom |
| Jazz Pharmaceuticals INC. | $75.12 | 2019-2024 | |
| Vanda Pharmaceuticals INC. | $63.57 | 2025 | Ponvory |
| Eisai INC. | $62.86 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.99 | 2023-2024 | Hyqvia |
| Mdd US Operations, LLC | $57.23 | 2019 | |
| Supernus Pharmaceuticals, INC. | $52.37 | 2019-2020 | |
| Ge Healthcare | $51.23 | 2020-2024 | |
| Acorda Therapeutics, INC | $47.33 | 2019-2023 | Inbrija, Ampyra |
| Kyowa Kirin, INC. | $40.61 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $40.17 | 2022 | |
| Abbott Laboratories | $39.96 | 2022-2024 | Infinity |
| Otsuka America Pharmaceutical, INC. | $37.09 | 2024-2025 | Rexulti |
| Horizon Therapeutics Plc | $35.20 | 2022-2023 | Uplizna |
| Boston Scientific Corporation | $30.20 | 2023 | Vercise |
| Mallinckrodt Enterprises LLC | $28.98 | 2019 | |
| Merz North America, INC. | $28.43 | 2019 | |
| Medtronic USA, INC. | $28.15 | 2019 | |
| Arbor Pharmaceuticals, INC. | $24.99 | 2021-2022 | |
| Avion Pharmaceuticals | $24.86 | 2022 | |
| Inspire Medical Systems, INC. | $21.15 | 2023 | Inspire |
| Axsome Therapeutics, INC. | $20.67 | 2025 | Symbravo |
| Grifols USA, LLC | $20.10 | 2025 | Gamunex-C |
| Impel Pharmaceuticals INC. | $19.47 | 2023 | Trudhesa |
| Neurelis, INC. | $18.26 | 2023 | Valtoco |
| Lundbeck LLC | $17.34 | 2025 | Rexulti |
| Livanova USA, INC. | $16.85 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Upsher-Smith Laboratories LLC | $16.52 | 2019 | |
| Nevro Corp. | $16.49 | 2024 | Senza |
| Medtronic, INC. | $15.74 | 2025 | Inceptiv |
| Ns Pharma, INC. | $15.17 | 2025 | Viltepso |
| Argenx US, INC. | $14.92 | 2024 | Vyvgart Hytrulo |
| Celgene Corporation | $14.79 | 2025 | Zeposia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Husam Alkhersam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.